drugset / Trial / NCT07113366

Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis

NCT07113366 ↗

Phase 1 Completed 30 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is designed to evaluate the efficacy and safety of a topical formulation containing Ficus awkeotsang Makino extract (FAE), derived from jelly fig, in participants with mild to moderate atopic dermatitis. Ficus awkeotsang is a traditional plant native to Taiwan.

Timeline

Start
2024-05-01
Primary completion
2024-06-01
Completion
2024-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ficus awkeotsang Makino extract Traditional medicine (herbal / TCM) 1 mg/ml Topical
Subject Ficus awkeotsang Makino extract Traditional medicine (herbal / TCM) 5 mg/ml Topical

Indications